Protocol GMP logo.jpg

GMP Certification

Good Manufacturing Practices (GMPs) have been established by the Natural Products

...
Label Information Logo

Label Information

Our labels are full disclosure with extended-wrap educational labels.  Each label

...
Science Logo

Science

Our expert team of highly qualified scientist and technicians work in tandem to develop new and

...
BROWSE OUR SITE
Home


References - Weight Management Protocol

1.    Kuriyan R, Raj T, Srinivas SK, Vaz M, Rajendran R, Kurpad AV.  Related   "Effect of Caralluma Fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women."  Appetite. 2007 May;48(3):338-44.     
 
2.    Nagle DG, Ferreira D, Zhou YD.   "Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives."  Phytochemistry. 2006 Sep;67(17):1849-55.     

3.    Kao YH, Chang HH, Lee MJ, Chen CL.  "Tea, obesity, and diabetes."  Mol Nutr Food Res. 2006 Feb;50(2):188-210.                 
4.    Wolfram S, Wang Y, Thielecke F.   "Anti-obesity effects of green tea: from bedside to bench." Mol Nutr Food Res. 2006 Feb;50(2):176-87.         

5.    Wolfram S, Wang Y, Thielecke F.   "Anti-obesity effects of green tea: from bedside to bench."  Mol Nutr Food Res. 2006 Feb;50(2):176-87.         

6.    Kuo KL, Weng MS, Chiang CT, Tsai YJ, Lin-Shiau SY, Lin JK.   "Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats."  J

7.    Norager CB, Jensen MB, Madsen MR, Laurberg S.   "Caffeine improves endurance in 75-yr-old citizens: a randomized, double-blind, placebo-controlled, crossover study." J Appl Physiol. 2005 Dec;99(6):2302-6.    
                
8.    Lopes JM, Aubier M, Jardim J, Aranda JV, Macklem PT.   "Effect of caffeine on skeletal muscle function before and after fatigue."  J Appl Physiol. 1983 May;54(5):1303-5.   
             
9.    Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O (2005) "Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans."  J Nutr 135(4):778-784.    

10.    Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O (2004) "Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans."  Am J Clin Nutr 79:1118-1125.  
         
11.    Thom E, Wadstein J, Gudmundsen O (2001) "Conjugated linoleic acid reduces body fat in healthy exercising humans." J int Med Res 29(5):392-396.    

12.    Smedman A, Vessby B (2001) "Conjugated linoleic acid supplementation in humans -- metabolic effects."  Lipids 36(8): 773-781.            

13.    Blankson H, Stakkestad JA,  Fagertun H,  Thom E, Wadstein J, Gudmundsen O (2000) "Conjugated Linoleic Acid Reduces Body Fat Mass in Overweight and Obese Humans." J Nutr 130(12):2943-2948. 
   
14.    Riserus U, Berglund L, Vessby B (2001)  "Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial."  Int J Obes 25:1129-1135.    
 
15.    Broquist HP (1994) Carnitine,  in Modern Nutrition in Health and Disease, 8th ed., Shils ME, Olson JA, Shike M (eds.) Lea & Febiger, Philadelphia, pp. 459-465.

16.    http://www.umm.edu/altmed/ConsSupplements/CarnitineLCarnitinecs.html#Precautions
 
17.  http://healthlibrary.epnet.com/GetContent.aspx?token=e0498803-7f62-4563-8d47-5fe33da65dd4&chunkiid=21676#P4  
     
18.    Stoecker BJ.  Chromium.  Modern Nutrition in Health and Disease. Tenth Edition, 2006.  Shils ME, et al Eds.  Lippincott, Williams, and Wilkins, Baltimore and Philadelphia.       
       
19.    Cefalu WT, Hu FB.  "Role of chromium in human health and in diabetes." Diabetes Care. 2004 Nov;27(11):2741-51.    
20.    Lukaski HC.  "Magnesium, zinc, and chromium nutriture and physical activity." Am J Clin Nutr. 2000 Aug;72(2 Suppl):585S-93S.  

21.    Lamson DS, Plaza SM.  "The safety and efficacy of high-dose chromium." Altern Med Rev. 2002 Jun;7(3):218-35.                 
22.    Vincent JB.  The biochemistry of chromium.  J Nutr. 2000 Apr;130(4):715-8. Review.  
           
23.    Source: Rink D, Roy S, Khanna S, Rink T, Bagchi D, Sen, CK.  Transcriptome of the subcutaneous adipose tissue in response to oral supplementation of type 2 Leprdb obese diabetic mice with niacin-bound chromium.  Physiol Genomics. 27: 370-379 (2006).                 
   
24.    Jain SK, Rains J and Rogier K, Effect of Niacin-Bound Chromium Complex (NBC) on IL-6 Secretion and Oxidative Stress Caused by High-Glucose (HG) in Cultured U937 Monocytes—Annual Meeting of the Federation of American Societies of Experimental Biology, 20(4):132, Abs. 376.4, April 2006.      
         
25.    Jain SK, Rains J and Jones K, Chromium-Supplementation Inhibits MCP-I, IL-6 and IL-8 Secretion and Oxidative Stress Caused by High-Glucose (HG) in Cultured U937 Monocytes —Annual Meeting of the American Diabetes Association, 66th Scientific Sessions, 55(1):A383,1659-P, June 2006.        

26.    Preuss HG, Jarrell ST, Scheckenbach R, Lieberman S, Anderson RA, Comparative Effects of Chromium, Vanadium and Gymnema Sylvestre on Sugar-Induced Blood Pressure Elevations in SHR, Journal of the American College of Nutrition, 17:116-123, 1998.         
        
27.    T. Yasmin, M.A., Shara, D. Bagchi, A. Kincaid, A. Limpach, R. Sandstrom, and M. Bagchi, Long-Term Safety Evaluation of a Novel Oxygen-Coordinated Niacin-bound Chromium (III) Complex, Annual Meeting of the American College of Nutrition, Reno, Nevada, Abs. 95, Pg. 465, Vol. 25, No. 5, October 5-8, 2006.        
        
28.    Yasmin T, Shara M, Bagchi M, Preuss HG, Bagchi D, Toxicological Assessment Of A Novel Niacin-Bound Chromium, Known To Ameliorate The Symptoms Of Metabolic Syndromes, Journal of the American College of Nutrition, 45th Annual Meeting, abs 77, October, 2004.        

29.    Bagchi M, Jensen N, Preuss HG, Bagchi D, Efficacy and Toxicological Assessment of a Novel, Niacin-Bound Chromium in Ameliorating Metabolic Disorders, 10th International Congress of Toxicology-Finland 197:abs. 354, July 2004.    

30.    Grant KE, Chandler RM, Castle AL, Ivy JL, Chromium and Exercise Training: Effect on Obese Women, Medicine & Science in Sports & Exercise, 29:992-998, 1997.          
     
31.    http://www.interhealthusa.com/faqs/chromemate_faqs.aspx    

32.    http://www.umm.edu/altmed/articles/chromium-000294.htm

33.    Cox GR, et al.  Effect of different protocols of caffeine intake on metabolism and endurance performance. J Appl Physiol. 2002 Sep;93(3):990-9.

34.    Bell DG, McLellan TM.  Effect of repeated caffeine ingestion on repeated exhaustive exercise endurance. Med Sci Sports Exerc. 2003 Aug;35(8):1348-54.             

35.    Norager CB, Jensen MB, Madsen MR, Laurberg S.  Caffeine improves endurance in 75-yr-old citizens: a randomized, double-blind, placebo-controlled, crossover study. J Appl Physiol. 2005 Dec;99(6):2302-6.           
     
36.    Doherty M, Smith P, Hughes M, Davison R.  Caffeine lowers perceptual response and increases power output during high-intensity cycling.  J Sports Sci. 2004 Jul;22(7):637-43.         

37.    Diepvens K, Westerterp KR, Westerterp-Plantenga MS.  Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R77-85.   
         
38.    Dulloo AG, Duret C, Rohrer D, et al.  Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999 Dec;70(6):1040-5.       
         
39.    Westerterp-Plantenga M, Diepvens K, Joosen AM, Berube-Parent S, Tremblay A.   Metabolic effects of spices, teas, and caffeine.  Physiol Behav. 2006 Aug 30;89(1):85-91.               
 
40.    Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB.  Changes in caffeine intake and long-term weight change in men and women.  Am J Clin Nutr. 2006 Mar;83(3):674-80.

41.    Panossian A, Wagner H.  Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.  Phytother Res. 2005 Oct;19(10):819-38.     

42.    Perfumi M, Mattioli L.  Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res. 2007 Jan;21(1):37-43.       
             
43.    Kimura Y, Sumiyoshi M.   Effects of various Eleutherococcus senticosus cortex on swimming time, natural killer activity and corticosterone level in forced swimming stressed mice.  J Ethnopharmacol. 2004 Dec;95(2-3):447-53.     

44.    Panossian A, Wagner H. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.  Phytother Res. 2005 Oct;19(10):819-38.     

45.    http://www.pdrhealth.com/drug_info/nmdrugprofiles/herbaldrugs/101340.shtml

46.    http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/gre_0319.shtml

47.    http://www.pdrhealth.com/drug_info/nmdrugprofiles/herbaldrugs/101250.shtml      
     
48.    Bruce CR, Brolin C, Turner N, et al.  Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification.  Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1231-7.       
     
49.    Sethumadhavan S, Chinnakannu P.  Carnitine and lipoic acid alleviates protein oxidation in heart mitochondria during aging process.  Biogerontology. 2006 Apr;7(2):101-9.      
   
50.    Pender C, Trentadue AR, Pories WJ, Dohm GL, Houmard JA, Youngren JF.  Expression of genes regulating malonyl-CoA in human skeletal muscle. J Cell Biochem. 2006 Oct 15;99(3):860-7.     

51.    Panneerselvam KS, Kumaran S. L-Carnitine and alpha-lipoic acid improves mitochondrial function during ageing process. Clin Nutr. 2006 May 9    

52.     [No authors listed]  Monograph. L-carnitine.  Altern Med Rev. 2005 Mar;10(1):42-50.     

53.    Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C.  Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.  Ann N Y Acad Sci. 2004 Nov;1033:79-91.

54.    Calvani M, Reda E, Arrigoni-Martelli E.  Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.  Basic Res Cardiol. 2000 Apr;95(2):75-83.      
           
55.    Gramignano G, et al.  Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy.  Nutrition. 2006 Feb;22(2):136-45.   
 
56.    Monograph. L-carnitine.  Altern Med Rev. 2005 Mar;10(1):42-50.

57.    Mondillo S, Faglia S, D'Aprile N, et al.  [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine]  Clin Ter. 1995 Dec;146(12):769-74. Italian.  
                 
58.    Al-Hasani H, Joost HG.  Nutrition-/diet-induced changes in gene expression in white adipose tissue. Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):589-603.    
         
59.    Azain MJ.  Role of fatty acids in adipocyte growth and development. J Anim Sci. 2004 Mar;82(3):916-24.       
 
60.    Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.  Pharmacol Ther. 2006 Mar;109(3):325-38.     

61.    Amer A, Breu J, McDermott J, et al.  5-Hydroxy-L-tryptophan suppresses food intake in food-deprived and stressed rats.  Pharmacol Biochem Behav. 2004 Jan;77(1):137-43.                 

62.    Cangiano C, Laviano A, Del Ben M,et al.  Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients.  Int J Obes Relat Metab Disord. 1998 Jul;22(7):648-54.   
         
63.    Birdsall TC.  5-Hydroxytryptophan: a clinically-effective serotonin precursor.  Altern Med Rev. 1998 Aug;3(4):271-80.             
64.    Kahn RS, Westenberg HG, Verhoeven WM, et al.   Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol. 1987 Jan;2(1):33-45.  
   
65.    Lardy H., Partridge B., Kneer N., and Wei Y. Ergosteroids: Induction of thermogenic enzymes in liver of rats treated with steroids derived from dehydroepiandrosterone. Proceedings of the National Academy of Sciences (1995) 92:6617-6619.

66.    Lardy H., Kneer N., Bellei M., and Bobyleva V. Induction of thermogenic enzymes by DHEA and its metabolites. Annals New York Academy of Sciences (1995) 774:171-179.

67.    Tyrrell H & Maher T: Tyrosine: Food supplement or therapeutic agent? J Nutr Env Med 1998; 8(4):349-359.  
             
68.    Paranjpe P, Patki P, Patwardhan B.   Ayurvedic treatment of obesity: a randomised double-blind, placebo-controlled clinical trial.  J Ethnopharmacol. 1990 Apr;29(1):1-11.             

69.    Tripathi YB, Malhotra OP, Tripathi SN.   Thyroid stimulating action of Z-guggulsterone obtained from Commiphora mukul. Planta Med. 1984 Feb;50(1):78-80.         

70.    Tripathi YB, Malhotra OP, Tripathi SN.  Thyroid Stimulating Action of Z-Guggulsterone Obtained from Commiphora mukul. Planta Med. 1984 Feb;50(1):78-80.           
     
71.    Panda S, Kar A. Withania somnifera and Bauhinia purpurea in the regulation of circulating thyroid hormone concentrations in female mice. J Ethnopharmacol. 1999 Nov 1;67(2):233-9.     

72.    Panda S, Kar A.  Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. J Pharm Pharmacol. 1998 Sep;50(9):1065-8.  
   
73.    Sufka KJ, Roach JT, Chambliss WG Jr, Broom SL, Feltenstein MW, Wyandt CM, Zeng L. Anxiolytic properties of botanical extracts in the chick social separation-stress procedure.  Psychopharmacology (Berl). 2001 Jan 1;153(2):219-24.         
74.    Garrison R, Chambliss WG.  Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.  Altern Ther Health Med. 2006 Jan-Feb;12(1):50-4.